Chapter 2: The effectiveness of lowering LDL cholesterol to prevent heart disease

In this video conversation series, Novartis Head of Global Drug Development and Chief Medical Officer Dr John Tsai and cardiologist Dr Steven Nissen discuss their perspectives and experiences around cardiovascular disease, the leading cause of death in the US. In Chapter 2 they speak about the effectiveness of lowering LDL cholesterol to prevent heart disease.
©2022 Novartis AG